APOE and Alzheimer disease: Inverse associations (not statistically significant) were observed between higher intake and AD [HR (95% CI) = 0.97 (0.90–1.04); p = 0.338] and memory decline [B (95% CI) = −0.02 (−0.08–0.05); p = 0.241], also in APOE4 carriers [B (95% CI) = 0.11 (−0.06–0.29); p = 0.202] and APOE4 non-carriers [B (95% CI) = −0.04 (−0.11–0.02); p = 0.211]